Prognostic Significance of Ribosome-related Genes Signature in Diffuse Large B Cell Lymphoma

Background: The diffuse large B-cell lymphoma (DLBCL) is a heterogeneous lymphoma with a dismal outcome, due to approximately 40% patients will be relapsed or refractory to the standard therapy of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP). Therefore, we need u...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Wenqi, Wang, Jinhuan, Jiang, Yanan, Hu, Xin, Tian, Ye, Chen, Long, Sun, Huimeng, Li, Yuhang, Liu, Su, Lv, Yangyang, Guo, Jing, Xu, Hong, Xing, Donghui, Zhai, Yixin, Tian, Linyan, Li, Cheng, He, Xiang, Luo, Kaiping, Pan, Yuan, Zhao, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969582/
https://www.ncbi.nlm.nih.gov/pubmed/36860924
http://dx.doi.org/10.7150/jca.80926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969582/
https://www.ncbi.nlm.nih.gov/pubmed/36860924
http://dx.doi.org/10.7150/jca.80926

Ejemplares similares